(Q33177387)

23 July 2017

Marimastat in recurrent colorectal cancer: exploratory evaluation of biological activity by measurement of carcinoembryonic antigen (English)

1 reference

recurrent colorectal cancer

23 July 2017

1 reference

1 reference

1 reference

Primrose JN

1

1 reference

23 July 2017

Bleiberg H

2

1 reference

23 July 2017

Daniel F

3

1 reference

23 July 2017

Van Belle S

4

1 reference

23 July 2017

Mansi JL

5

1 reference

23 July 2017

Seymour M

6

1 reference

23 July 2017

Johnson PW

7

1 reference

23 July 2017

Neoptolemos JP

8

1 reference

23 July 2017

Baillet M

9

1 reference

23 July 2017

Barker K

10

1 reference

23 July 2017

Berrington A

11

1 reference

23 July 2017

Brown PD

12

1 reference

23 July 2017

Millar AW

13

1 reference

23 July 2017

Lynch KP

14

1 reference

23 July 2017

language of work or name

English

0 references

publication date

1 February 1999

1 reference

British Journal of Cancer

23 July 2017

1 reference

23 July 2017

79

1 reference

23 July 2017

3-4

1 reference

23 July 2017

509-514

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6690079

23 July 2017

0 references

cites work

DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362442

Conversion of highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitor

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362442

Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362442

Matrix metalloproteinase inhibition: a review of anti-tumour activity

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362442

Matrix metalloproteinases in brain injury

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362442

Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362442

The use of tumour markers CEA, CA-195 and CA-242 in evaluating the response to chemotherapy in patients with advanced colorectal cancer.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362442

Interstitial collagenase gene expression in colonic neoplasia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362442

Significance of a fall in serum CEA concentration in patients treated with cytotoxic chemotherapy for disseminated colorectal cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362442

Re-operation for recurrent colorectal cancer: the importance of early diagnosis for resectability and survival

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362442

Metalloproteinases and their inhibitors in matrix remodeling

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362442

Assessment of serial carcinoembryonic antigen (CEA) assays in postoperative detection of recurrent colorectal cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362442

Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362442

Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362442

M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer

31 October 2018

1 reference

12 December 2020

Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis

1 reference

12 December 2020

Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models

1 reference

12 December 2020

Slope analysis of CA19-9 and CEA for predicting recurrence in colorectal cancer patients

1 reference

12 December 2020

Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study

1 reference

12 December 2020

Prognostic variable in patients with advanced colorectal cancer treated with fluorouracil and leucovorin-based chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690079

7 January 2021

Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690079

7 January 2021

Second-look operation for recurrent colorectal cancer based on carcinoembryonic antigen and imaging techniques

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690079

7 January 2021

Matrilysin is associated with progression of colorectal tumor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690079

7 January 2021

Structural biochemistry and activation of matrix metalloproteases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690079

7 January 2021

Results of single and repeat dose studies of the oral matrix metalloproteinase inhibitor marimastat in healthy male volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690079

7 January 2021

Oral administration of a matrix metalloproteinase inhibitor, CGS 27023A, protects the cartilage proteoglycan matrix in a partial meniscectomy model of osteoarthritis in rabbits

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690079

7 January 2021

Enzymes as prognostic markers and therapeutic indicators in patients with cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690079

7 January 2021

Identifiers

DOI

10.1038/SJ.BJC.6690079

1 reference

Dimensions Publication ID

23 July 2017

0 references

1 reference

23 July 2017

1 reference